Evidence map›Paper›PMID 42878310›Full record

ArticleImmunity, inflammation and disease2026

Dynamic Shifts in Lymphocyte Subsets During the Menopausal Transition and Sexual Dimorphism in Immunosenescence.

Ci Xuan, Li He, Zhou Bohan, Xu Junming, Li Qingchao, Huang Junting

Abstract read
In one paragraph

Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ci XuanDepartment of Blood Transfusion, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0009-0000-8850-0111
Li HeDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0009-0004-5768-0999
Zhou BohanDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0009-0004-7713-6093
Xu JunmingDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0009-0006-6792-9297
Li QingchaoNanjing Southeast Research Institute, Nanjing, Jiangsu, China.
Huang JuntingDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0003-2582-2687

Funding

Open Fund of the National Innovation Center for Advanced Medical Devices NMED2025KF-03-017The 2023 Enhancement Program for Undergraduate Innovation Capability of Guangzhou Medical University 2023-10
6 · The paper itself

Abstract

backgroundImmunosenescence demonstrates marked sexual dimorphism, yet the dynamic changes in lymphocyte subsets across the female menopausal transition are poorly defined. This study characterized these age- and sex-related immune variations in a large Chinese cohort.

methodsIn this cross-sectional study, we analyzed 4209 healthy adults using flow cytometry to quantify lymphocyte subsets and PD-1 expression. Females were stratified by age and reproductive stage. Sex comparisons were performed after propensity score age-matching.

resultsAnalysis of the female cohort revealed dynamic immune shifts during the menopausal transition, characterized by a "scissor-like" pattern: CD3

conclusionThese findings suggest that the perimenopausal period represents a key phase of immune remodeling in women, and support the integration of sex and reproductive stage into future immunosenescence research and clinical strategies.

Indexed as

ImmunosenescenceLymphocyte SubsetsMenopauseSex CharacteristicsAdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCross-Sectional StudiesFemaleHumansMaleMiddle AgedProgrammed Cell Death 1 ReceptorPDCD1 protein, humanProgrammed Cell Death 1 ReceptorChinese populationimmunosenkescencelymphocyte subsetsmenopausal transitionPD‐1sexual dimorphism

Identifiers

PMID42878310
PMCPMC13671003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.